Found: 41
Select item for more details and to access through your institution.
Feasibility of robotic-assisted partial nephrectomy for complete remission of metastatic renal cell carcinoma after long exposure to immune checkpoint inhibitors (UroCCR-106).
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 1, p. 84, doi. 10.1016/j.clgc.2023.11.001
- By:
- Publication type:
- Article
Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv-UroCCR 79 Study.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 1, p. 194, doi. 10.1016/j.clgc.2022.07.002
- By:
- Publication type:
- Article
Impact of <sup>18</sup> FDG-PET CT in the Management of Muscle Invasive Bladder Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 3, p. 297.e1, doi. 10.1016/j.clgc.2022.01.009
- By:
- Publication type:
- Article
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Indications et place des immunothérapies dans la stratégie thérapeutique des cancers en 2023.
- Published in:
- Revue Immunité & Cancer, 2024, v. 8, n. 1, p. 4
- By:
- Publication type:
- Article
Indications et place des immunothérapies dans la stratégie thérapeutique des cancers en 2022.
- Published in:
- Revue Immunité & Cancer, 2023, v. 7, n. 1, p. 7
- By:
- Publication type:
- Article
Immunothérapie et cancer de la vessie : question de séquence ? Question d'agent ?
- Published in:
- Revue Immunité & Cancer, 2022, v. 6, n. 3, p. 125
- By:
- Publication type:
- Article
Indications et place des immunothérapies dans la stratégie thérapeutique des cancers.
- Published in:
- Revue Immunité & Cancer, 2022, v. 6, n. 1, p. 5
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 7, p. 1, doi. 10.1007/s11095-020-02861-5
- By:
- Publication type:
- Article
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1780, doi. 10.3390/cancers16091780
- By:
- Publication type:
- Article
Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5558, doi. 10.3390/cancers15235558
- By:
- Publication type:
- Article
Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1048, doi. 10.3390/cancers15041048
- By:
- Publication type:
- Article
Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6230, doi. 10.3390/cancers14246230
- By:
- Publication type:
- Article
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5548, doi. 10.3390/cancers13215548
- By:
- Publication type:
- Article
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/3449660
- By:
- Publication type:
- Article
Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with Everolimus.
- Published in:
- 2010
- By:
- Publication type:
- Report
Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- Report
Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2250, doi. 10.1002/cam4.3687
- By:
- Publication type:
- Article
The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
- Published in:
- Carcinogenesis, 2004, v. 25, n. 8, p. 1443, doi. 10.1093/carcin/bgh147
- By:
- Publication type:
- Article
Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers.
- Published in:
- Carcinogenesis, 2004, v. 25, n. 4, p. 541
- By:
- Publication type:
- Article
Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 6, p. 745, doi. 10.1002/ijc.11017
- By:
- Publication type:
- Article
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study.
- Published in:
- BJU International, 2019, v. 123, n. 5, p. 804, doi. 10.1111/bju.14581
- By:
- Publication type:
- Article
Testicular-sparing surgery for bilateral or monorchide testicular tumours: a multicenter study of long-term oncological and functional results.
- Published in:
- BJU International, 2014, v. 114, n. 6, p. 860, doi. 10.1111/bju.12549
- By:
- Publication type:
- Article
Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year.
- Published in:
- Current Urology Reports, 2012, v. 13, n. 1, p. 16, doi. 10.1007/s11934-011-0232-y
- By:
- Publication type:
- Article
Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 12, p. 1561, doi. 10.1002/pds.4228
- By:
- Publication type:
- Article
Day-case robotic-assisted partial nephrectomy: feasibility and preliminary results of a prospective evaluation (UroCCR-25 AMBU-REIN study).
- Published in:
- World Journal of Urology, 2022, v. 40, n. 6, p. 1351, doi. 10.1007/s00345-020-03283-z
- By:
- Publication type:
- Article
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 1, p. 17, doi. 10.3390/cells11010017
- By:
- Publication type:
- Article
Gemcitabine–Oxaliplatin Combination in Heavily Pretreated Metastatic Breast Cancer: A Pilot Study on 43 Patients.
- Published in:
- Breast Journal, 2007, v. 13, n. 2, p. 165, doi. 10.1111/j.1524-4741.2007.00391.x
- By:
- Publication type:
- Article
The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 12, p. 1597, doi. 10.1080/0284186X.2021.1978540
- By:
- Publication type:
- Article
Prognostic factors for cancer patient admitted to a medical intensive care unit.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 4, p. 458, doi. 10.1080/0284186X.2019.1711171
- By:
- Publication type:
- Article
Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Management of Immune Checkpoint Inhibitor Toxicities.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 9139, doi. 10.2147/CMAR.S218756
- By:
- Publication type:
- Article
Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 1, p. 81, doi. 10.1007/s11523-012-0245-6
- By:
- Publication type:
- Article
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
- Published in:
- Oncologist, 2024, v. 29, n. 2, p. 142, doi. 10.1093/oncolo/oyad231
- By:
- Publication type:
- Article
Optimal management of renal cell carcinoma in the elderly: a review.
- Published in:
- Clinical Interventions in Aging, 2013, v. 8, p. 433, doi. 10.2147/CIA.S30765
- By:
- Publication type:
- Article
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives.
- Published in:
- Therapeutics & Clinical Risk Management, 2022, v. 18, p. 619, doi. 10.2147/TCRM.S251673
- By:
- Publication type:
- Article
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
- Published in:
- BMC Medical Research Methodology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12874-021-01285-y
- By:
- Publication type:
- Article
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
- Published in:
- 2021
- By:
- Publication type:
- journal article